Company Name:

Stella Therapeutics is developing novel small molecules (ST drugs) that hold the promise of treating malignant tumors through a unique mechanism of action by initially blocking the migration and proliferation of tumor cells, and then selectively killing them through the induction of apoptosis (programmed cell death).

Contact Information